Drugs / Pentaerythrithyltetranitrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01355822 | Apr 2002 → Jan 2008 | — | University of Jena | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pentaerythrithyltetranitrate | “Pentaerythrithyltetranitrate: 80 mg orally twice a day” NCT01355822 ↗ |
| Known as | PETN | “The aim of this study is to evaluate the effectiveness of the long-lasting NO donor pentarythrithyltetranitrate (PETN) to reduce the likelihood of adverse pregnancy outcomes...” NCT01355822 ↗ |
| Modality | Other / unclassified | “long-lasting NO donor pentarythrithyltetranitrate (PETN)” NCT01355822 ↗ |
| Route | Oral | “Pentaerythrithyltetranitrate: 80 mg orally twice a day” NCT01355822 ↗ |